Pacific Biosciences of California, Inc. (PACB)
1.94
-0.10
(-4.90%)
USD |
NASDAQ |
Jan 09, 16:00
1.93
-0.01
(-0.52%)
After-Hours: 20:00
Pacific Biosciences of California Research and Development Expense (Annual): 129.02M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 456.03M |
| Twist Bioscience Corp. | 80.28M |
| Beam Therapeutics, Inc. | 367.56M |
| Boston Scientific Corp. | 1.615B |
| Bruker Corp. | 376.50M |